Mamotest

Mexico City, Mexico

AI Digital solution transforming care delivery by democratizing access to screening & diagnosis while providing efficient path to treatment.

$3.3M raised

Mar 2023

Seed

Top Investors

MerckSonen CapitalMerck Global Health Innovation FundJohnson & Johnson Impact VenturesSky High

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mamotest raised?

Mamotest has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in March 2023.

Who are Mamotest's investors?

Mamotest's investors include Merck, Sonen Capital, Merck Global Health Innovation Fund, Johnson & Johnson Impact Ventures, Sky High.

Where is Mamotest headquartered?

Mamotest is headquartered in Mexico City, Mexico.

What does Mamotest do?

AI Digital solution transforming care delivery by democratizing access to screening & diagnosis while providing efficient path to treatment.

What stage is Mamotest at?

Mamotest is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 27, 2023.

MLA

"Mamotest — Funding & Investors." VCBacked, March 27, 2023, https://www.vcbacked.co/company/mamotest. Accessed June 17, 2026.

APA

VCBacked. (2023). Mamotest — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/mamotest

Wikipedia (cite web)

{{cite web |title=Mamotest — Funding & Investors |url=https://www.vcbacked.co/company/mamotest |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 27, 2023.